Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04602078
Title Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma (AUREA)
Acronym AUREA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spanish Oncology Genito-Urinary Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.